Synergy between tobramycin and trivalent chromium ion in electrochemical control of Pseudomonas aeruginosa
Source abstract
Abstract
Unlabelled We recently demonstrated that the effectiveness of tobramycin (Tob), an aminoglycoside, against antibiotic-tolerant persister cells of Pseudomonas aeruginosa can be enhanced by electrochemical factors generated from direct currents (DC). Supplementation of Ni(II), Cr(III) and Fe(II) during carbon-mediated DC treatment revealed that these metal cations promote killing of persister cells in the presence of tobramycin, which led to our hypothesis that specific interactions between Tob and some metal ions contribute to the synergistic killing of persister cells. In this study, the interactions between selected metal cations and Tob were investigated using (1)H-(13)C HSQC NMR. Increase in the concentration of Cr(III) (in the form of [CrCl2(H2O)4](+)) in solutions containing Tob was found to shift the HSQC NMR peaks of Tob to new positions, suggesting the formation of a Cr(III)-Tob complex. Crystal field effects and electrochemical properties of the complex were further studied using UV-visible spectroscopy and cyclic voltammetry, which led to the finding that the Cr(III)-Tob complex has increased affinity with negatively charged nucleic acids. These findings are helpful for understanding the mechanism of electrochemical control of bacterial cells and for developing more effective antimicrobial therapies based on aminoglycosides and electrochemical species released from various metallic biomaterials. Statement of significance Medical device associated infections present a major challenge to healthcare and the quality of life of affected individuals. This problem is further exacerbated by the emergence of multidrug resistant pathogens. Thus, alternative methods for microbial control are urgently needed. Recently, we reported synergy between tobramycin and low-level electrochemical currents generated using stainless steel electrodes in killing bacterial persister cells, a dormant population with high-level intrinsic tolerance to antibiotics. In this article, we describe how electrically-induced interaction between aminoglycosides and certain metal cations enhance the potency of tobramycin in bacterial killing. The findings will help design new methods for controlling infections through electrochemical disruption of cellular function and associated drug resistance.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bacterial biofilms and quorum sensing · Microbial Fuel Cells and Bioremediation · Bacterial Genetics and Biotechnology
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (57)
Show source-provided references
1. Bacterial biofilms and the bioelectric effect10.1128/AAC.40.9.2012 ↗
2. Bioelectric effect and bacterial biofilms. A systematic review10.1177/039139880803100906 ↗
3. Mechanism of electrical enhancement of efficacy of antibiotics in killing biofilm bacteria10.1128/AAC.38.12.2803 ↗
4. Differential gene expression to investigate the effects of low-level electrochemical currents on Bacillus subtilis10.1186/2191-0855-1-39 ↗
5. Electrochemical biofilm control: a review10.1080/08927014.2015.1105222 ↗
6. Prevention of pin tract infection in external stainless steel fixator frames using electric current in a goat model10.1016/j.biomaterials.2007.01.001 ↗
7. Pathogenesis and prevention of biomaterial centered infections10.1023/A:1016175502756 ↗
8. Surface immobilized bisphosphonate improves stainless-steel screw fixation in rats10.1016/j.biomaterials.2003.08.049 ↗
9. Comparative study on corrosion resistance and in vitro biocompatibility of bulk nanocrystalline and microcrystalline biomedical 304 stainless steel10.1016/j.dental.2011.03.009 ↗
10. Metal ion release after total hip replacement10.1016/0142-9612(80)90016-2 ↗
11. Metal release from dental biomaterials10.1016/0142-9612(86)90097-9 ↗
12. Serum concentrations of chromium, cobalt and nickel after total hip replacement: a six month study10.1016/0142-9612(83)90003-0 ↗
13. Comparison of metal release from various metallic biomaterials in vitro10.1016/j.biomaterials.2004.02.005 ↗
14. Antibacterial surfaces: the quest for a new generation of biomaterials10.1016/j.tibtech.2013.01.017 ↗
15. Controlled release of biologically active silver from nanosilver surfaces10.1021/nn102272n ↗
16. Reducing implant-related infections: active release strategies10.1039/b515219b ↗
17. Controlling Pseudomonas aeruginosa persister cells by weak electrochemical currents and synergistic effects with tobramycin10.1016/j.biomaterials.2012.06.092 ↗
18. Persister cells10.1146/annurev.micro.112408.134306 ↗
19. Sensitizing Pseudomonas aeruginosa to antibiotics by electrochemical disruption of membrane functions10.1016/j.biomaterials.2015.10.007 ↗
20. Comparative activity of sisomicin, gentamicin, kanamycin, and tobramycin10.1128/AAC.2.6.431 ↗
21. Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa10.1128/AAC.6.4.442 ↗
22. Comparative study of tobramycin and gentamicin with special reference to anti-pseudomonas activity10.1002/cpt1973141104 ↗
23. Comparative activity of netilmicin, gentamicin, amikacin, and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae10.1128/AAC.10.4.592 ↗
24. How antibiotics kill bacteria: from targets to networks10.1038/nrmicro2333 ↗
25. Electrostatic interactions in RNA aminoglycosides binding10.1021/ja9715105 ↗
26. Antagonistic effect of calcium in serum on the activity of tobramycin against Pseudomonas10.1128/AAC.1.6.466 ↗
27. Effect of cation content of agar on the activity of gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa10.1093/infdis/137.2.103 ↗
28. Cation components of Mueller-Hinton agar affecting testing of Pseudomonas aeruginosa susceptibility to gentamicin10.1128/AAC.17.1.55 ↗
29. Tobramycin and FDA-approved iron chelators eliminate Pseudomonas aeruginosa biofilms on cystic fibrosis cells10.1165/rcmb.2008-0299OC ↗
30. Sambrook · 2001
31. HPLC determination of tobramycin in a simulated body fluid10.1016/j.microc.2008.04.003 ↗
32. High-efficiency water oxidation and energy storage utilizing various reversible redox mediators under visible light over surface-modified WO 310.1039/C3RA47772J ↗
33. Monitoring hammerhead ribozyme-catalyzed cleavage with a fluorescein-labeled substrate: effects of magnesium ions and antibiotic inhibitors. A biochemistry laboratory: Part 210.1021/ed076p651 ↗
34. Synthesis and purification of a hammerhead ribozyme and a fluorescein-labeled RNA Substrate. A biochemistry laboratory: Part 110.1021/ed076p648 ↗
35. R. Schroeder, M.G. Wallis, RNA-binding antibiotics, Landes Bioscience Georgetown (2001).
36. Inhibition of the hammerhead ribozyme by neomycin
37. Complete 1H and 13C NMR chemical shift assignments for some N-polyformylated aminoglycoside antibiotics10.1080/00387019508011655 ↗
38. 1H NMR studies of Cr (III)–imidazole complexes: can 1 H NMR be used as a probe of Cr–guanine DNA adducts?10.1016/S0020-1693(02)01341-5 ↗
39. Nuclear magnetic resonance studies of multinuclear chromium assemblies10.1016/S0277-5387(00)81619-8 ↗
40. Carbon-13 NMR studies of oxo-centered trinuclear chromium (III) complexes of the general formula [Cr 3 O (O 2 CR) 6 (L) 3]+(R=Me, Ph; L=H 2 O, py)10.1016/0584-8539(94)E0003-S ↗
41. Synthesis and characterization of symmetric and unsymmetric oxo-bridged trinuclear chromium benzoate complexes: crystal and molecular structure of [Cr 3 O (O 2 CPh) 6 (py) 3] ClO 410.1016/0020-1693(93)03766-4 ↗
42. The hydration isomers of chromium (III) chloride10.1021/ed049p204 ↗
43. Spectra of Cr (III) complexes. An inorganic chemistry experiment10.1021/ed044p101 ↗
44. Kinetics and mechanism of the reaction between chromium (III) and 3, 4-dihydroxy-phenyl-propenoic acid (caffeic acid) in weak acidic aqueous solutions
45. Wang · 2006
46. The electrochemistry of gold: I the redox behaviour of the metal in aqueous media10.1007/BF03214756 ↗
47. Cyclic voltammetric study of biologically active metal ions with norfloxacin
48. Metabolic effects of secretin10.1016/j.ygcen.2012.11.017 ↗
49. Critical role of chromium (Cr)-DNA interactions in the formation of Cr-induced polymerase arresting lesions10.1021/bi020452j ↗
50. Analysis of the binding sites of chromium to DNA and protein in vitro and in intact cells10.1093/carcin/13.12.2341 ↗
51. A study of the interaction of Cr (III) complexes and their selective binding with B-DNA: a molecular modeling approach10.1080/07391102.2002.10506809 ↗
52. The nutritional supplement chromium (III) tris (picolinate) cleaves DNA10.1021/tx9900167 ↗
53. Oxygen radical-mediated DNA damage by redox-active chromium (III) complexes10.1021/bi00161a049 ↗
54. Cr (III)-mediated crosslinks of glutathione or amino acids to the DNA phosphate backbone are mutagenic in human cells10.1093/nar/26.8.2024 ↗
55. Genotoxicity of tri-and hexavalent chromium compounds In vivo and their modes of action on DNA damage In vitro10.1371/journal.pone.0103194 ↗
56. Uptake of metals by bacterial polysaccharides10.1111/j.1365-2672.1993.tb05155.x ↗
57. Bacterial heavy metal resistance: new surprises10.1146/annurev.micro.50.1.753 ↗